BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats.

Peptides 2019 Apr 14;114:44-49. Epub 2019 Apr 14.

National Institute of Science and Technology for Structural Biology and Bioimaging (INBEB-INCT), Federal University of Rio de Janeiro, Rio de Janeiro 21941-590, Brazil. Electronic address:

Amylin analogs are important adjunctive drugs in the treatment of diabetes mellitus. However, a dual therapy with insulin involves inconvenient multiple injections. Here we describe a novel n-terminal PEGylated human amylin analog - BZ043 - and its potential to improve the control of glycemia using lower doses of insulin. The effect of BZ043 over the insulin-mediated control of fed-glycemia was investigated in rats with streptozotocin-induced diabetes treated with the basal analog glargine (GLAR). Fasted rats (3 h) received a single treatment of BZ043 (16, 64 or 128 nmol/kg), GLAR (1.5 IU or 6.0 IU) or BZ043 plus GLAR low dose (1.5 IU) in separate injections, and had free access to 5% glucose rich chow and water. BZ043 dose-proportionally prevented the meal-related increase of glycemia, and the co-treatment (64 or 128 nmol/kg) with GLAR restored normoglycemia without abrupt variations of glycemia. BZ043 showed a prolonged anti-hyperglycemic effect and, together with GLAR, promoted a long-lasting normoglycemia, in vivo. We conceive that combining BZ043 and GLAR in a fixed-ratio co-formulation might conveniently improve the control of diabetes mellitus.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.peptides.2019.04.004DOI Listing
April 2019
1 Read

Publication Analysis

Top Keywords

amylin analog
8
diabetes mellitus
8
128 nmol/kg glar
8
bz043 glar
8
bz043
8
improve control
8
glar
6
basal analog
4
fed-glycemia investigated
4
analog glargine
4
investigated rats
4
variations glycemia
4
rats streptozotocin-induced
4
abrupt variations
4
control fed-glycemia
4
streptozotocin-induced diabetes
4
treated basal
4
diabetes treated
4
insulin-mediated control
4
bz043 potential
4

Similar Publications